<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Connexin hemichannels can open during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, resulting in loss of membrane potential, calcium influx, and release of <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, we tested the hypothesis that opening of hemichannels after <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> may contribute to delayed evolution of injury </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We infused a mimetic <z:chebi fb="7" ids="16670">peptide</z:chebi> that blocks connexin 43 hemichannels into the lateral ventricle of chronically instrumented fetal sheep in utero at 128 ± 1 days gestation (term is 147 days), starting 90 minutes after 30 minutes of severe <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> induced by reversible bilateral carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp>, for either 1 or 25 hours </plain></SENT>
<SENT sid="3" pm="."><plain>Sheep were killed 7 days later </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: <z:chebi fb="7" ids="16670">Peptide</z:chebi> infusion was associated with a graded improvement in recovery of electroencephalographic power after 7 days recovery, from -13 ± 1.9 dB (n = 7) after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-vehicle to -9 ± 1.6 dB (n = 7) after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-short infusion and -5 ± 1.6 dB after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-long infusion (n = 6, p &lt; 0.05) </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="7" ids="16670">Peptide</z:chebi> infusion was associated with reduced <z:hpo ids='HP_0001250'>seizure</z:hpo> activity after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, less frequent <z:hpo ids='HP_0002133'>status epilepticus</z:hpo> (p &lt; 0.05), and earlier return of sleep state cycling (p &lt; 0.05) </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">Ischemia</z:e>-long infusion (but not <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-short infusion) was associated with improved survival of oligodendrocytes in intragyral and periventricular white matter (p &lt; 0.05) and <z:mp ids='MP_0002176'>increased brain weight</z:mp> (p &lt; 0.05) </plain></SENT>
<SENT sid="7" pm="."><plain><z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">Ischemia</z:e>-long infusion was associated with an intermediate estimate of surviving neurons in the parasagittal cortex of 2.9 ± 0.8 × 10(6), in comparison to sham control (4.3 ± 0.9 × 10(6)) or <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-vehicle (1.5 ± 0.4 × 10(6); p &lt; 0.05 vs sham control) </plain></SENT>
<SENT sid="8" pm="."><plain>INTERPRETATION: These data support the hypothesis that opening of connexin hemichannels is a significant mediator of postischemic white and gray matter dysfunction and injury </plain></SENT>
</text></document>